Swarajya

Our View
MagazineHeadlinesVideosस्वराज्यBooksEconomyCultureAdvertise
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economy
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • Weekend Issues Archive
  • News Brief
  • Subscriber login
  • Politics
  • Economy
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • Weekend Issues Archive
  • News Brief

Bharat Biotech

PM Modi Likely To Be Vaccinated In Second Phase Of Covid-19 Immunisation Drive In March-April: Report
PM Modi Likely To Be Vaccinated In Second Phase Of Covid-19 Immunisation Drive In March-April: ReportSwarajya StaffJan 21, 2021 07:30 AM
We Need A Dual  Strategy For Covid Vaccine – Market-Based Pricing For Those Who Can Afford It 
We Need A Dual Strategy For Covid Vaccine – Market-Based Pricing For Those Who Can Afford It R JagannathanJan 20, 2021 06:51 AM
Here’s How India’s Covid Vaccines Are Likely To Play A Major Role In Firming India-Nepal Ties
Here’s How India’s Covid Vaccines Are Likely To Play A Major Role In Firming India-Nepal TiesJaideep MazumdarJan 13, 2021 09:21 AM
Covaxin: Bharat Biotech Supplying 16.5 Lakh Doses Of Its Covid-19 Vaccine Free Of Cost To Government
Covaxin: Bharat Biotech Supplying 16.5 Lakh Doses Of Its Covid-19 Vaccine Free Of Cost To GovernmentSwarajya StaffJan 13, 2021 08:44 AM
Bharat Biotech To Begin Phase-1 Trials Of Single Dose, Intranasal Covid-19 Vaccine In February-March
Bharat Biotech To Begin Phase-1 Trials Of Single Dose, Intranasal Covid-19 Vaccine In February-MarchSwarajya StaffJan 8, 2021 11:59 AM
Brazil Turns To India After Chinese Covid-19 Vaccine Candidates Run Into Major Credibility Crisis
Brazil Turns To India After Chinese Covid-19 Vaccine Candidates Run Into Major Credibility CrisisIANSJan 6, 2021 05:21 AM
Bharat Biotech Plans Covaxin Testing On Children As Young As Two Years; To Submit A Proposal To DCGI's Expert Panel Soon
Bharat Biotech Plans Covaxin Testing On Children As Young As Two Years; To Submit A Proposal To DCGI's Expert Panel SoonSwarajya StaffJan 5, 2021 06:08 AM
'Covaxin Is 200 Per Cent Safe': Bharat Biotech CMD Hits Out At Detractors Of Indian Covid-19 Vaccine
'Covaxin Is 200 Per Cent Safe': Bharat Biotech CMD Hits Out At Detractors Of Indian Covid-19 VaccineSwarajya StaffJan 4, 2021 02:44 PM
Indian Drug Regulator DCGI Approves Covid-19 Vaccines of AstraZeneca And Bharat Biotech
Indian Drug Regulator DCGI Approves Covid-19 Vaccines of AstraZeneca And Bharat Biotech Swarajya StaffJan 3, 2021 07:21 AM
Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's Covaxin
Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's CovaxinSwarajya StaffJan 3, 2021 02:50 AM
Covaxin Can Deal With New Strains Of Coronavirus Too: Bharat Biotech
Covaxin Can Deal With New Strains Of Coronavirus Too: Bharat BiotechIANSDec 30, 2020 02:27 AM
COVAXIN: Bharat Biotech Again Applies For Emergency Use Approval Of Its Covid-19 Vaccine Candidate
COVAXIN: Bharat Biotech Again Applies For Emergency Use Approval Of Its Covid-19 Vaccine CandidateIANSDec 24, 2020 02:43 AM
Serum Institute Submits Additional Data Sought By India's Drug Regulator For Emergency Approval Of Covishield Vaccine
Serum Institute Submits Additional Data Sought By India's Drug Regulator For Emergency Approval Of Covishield VaccineIANSDec 23, 2020 02:50 AM
COVID-19: Bharat Biotech To Begin Phase-1 Trials Of Its Intranasal Vaccine Next Month
COVID-19: Bharat Biotech To Begin Phase-1 Trials Of Its Intranasal Vaccine Next MonthSwarajya StaffDec 9, 2020 10:15 AM
COVID-19 Diplomacy: India To Take At Least 60 Heads Of Foreign Missions To Facilities Of Vaccine Makers In Hyderabad
COVID-19 Diplomacy: India To Take At Least 60 Heads Of Foreign Missions To Facilities Of Vaccine Makers In HyderabadSwarajya StaffDec 9, 2020 06:29 AM
Hyderabad-Based Bharat Biotech Begins Third Stage Clinical Trials Of Covid-19 Vaccine, To Enroll 26,000 Participants
Hyderabad-Based Bharat Biotech Begins Third Stage Clinical Trials Of Covid-19 Vaccine, To Enroll 26,000 ParticipantsSwarajya StaffNov 17, 2020 03:50 AM
COVAXIN Developer Bharat Biotech To Invest Rs 300 Crore To Set Up Facility In Odisha To Produce 10 Types Of Vaccines
COVAXIN Developer Bharat Biotech To Invest Rs 300 Crore To Set Up Facility In Odisha To Produce 10 Types Of VaccinesSwarajya StaffNov 7, 2020 04:48 AM
India's First Indigenously Developed Covid-19 Vaccine Could Be Ready For Use As Early As February Next Year: Report
India's First Indigenously Developed Covid-19 Vaccine Could Be Ready For Use As Early As February Next Year: ReportSwarajya StaffNov 5, 2020 10:27 AM
Bharat Biotech And Serum Institute To Soon Begin Late-Stage Clinical Trials Of Intranasal COVID-19 Vaccines
Bharat Biotech And Serum Institute To Soon Begin Late-Stage Clinical Trials Of Intranasal COVID-19 VaccinesSwarajya StaffOct 19, 2020 04:43 AM
Bharat Biotech Set To Begin Phase 3 Clinical Trials Of Its Indigenous Covid-19 Vaccine 'Covaxin', Seeks DCGI Nod
Bharat Biotech Set To Begin Phase 3 Clinical Trials Of Its Indigenous Covid-19 Vaccine 'Covaxin', Seeks DCGI NodSwarajya StaffOct 9, 2020 04:08 AM
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype